ANTI-TACE ANTIBODY MOLECULES AND THEIR USES
    12.
    发明申请
    ANTI-TACE ANTIBODY MOLECULES AND THEIR USES 审中-公开
    抗体抗体分子及其用途

    公开(公告)号:US20140050738A1

    公开(公告)日:2014-02-20

    申请号:US13981697

    申请日:2012-01-30

    Abstract: Anti-TACE (ADAM17) antibodies are disclosed that for the first time in the art are capable of binding to TACE, of acting as antagonists of one or more its biological activities, in particular by binding to TACE in a cross domain binding mode in which residues in both the catalytic domain and in the cysteine rich/disintegrin domains (Dis-Cys) are involved in antibody binding to TACE, helping to improve the specificity of the antibody binding and/or helping to improve inhibition of TACE biological activity. The therapeutic uses of the antibodies, in particular for the treatment of cancer are disclosed.

    Abstract translation: 公开了抗TACE(ADAM17)抗体,本领域首次能够结合TACE,作为一种或多种其生物学活性的拮抗剂,特别是通过以交叉结构结合模式结合TACE,其中 催化结构域和半胱氨酸富集/去整合素结构域(Dis-Cys)中的残基都参与与TACE的抗体结合,有助于改善抗体结合的特异性和/或有助于改善TACE生物活性的抑制。 公开了抗体的治疗用途,特别是治疗癌症。

Patent Agency Ranking